Immunization, measles second dose (% of children by the nationally) in Malaysia
Malaysia: Immunization, measles second dose (% of children by the nationally) was 93.0% in 2024. ▬ Flat
Immunization, measles second dose in Malaysia, 2005–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
Malaysia recorded 93.0% for immunization, measles second dose in 2024.
The figure is down 2.1% on the previous year and down 6.1% over ten years.
Over the whole period, immunization, measles second dose in Malaysia peaked at 99.0% in 2012 and was at its lowest, 84.0%, in 2020.
Malaysia ranks 45th of 178 countries on this measure, in the top quarter.
Immunization, measles second dose (% of children by the nationally) in Malaysia, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2005 | 91.0% | — |
| 2006 | 90.0% | -1.1% |
| 2007 | 92.0% | +2.2% |
| 2008 | 93.0% | +1.1% |
| 2009 | 95.0% | +2.2% |
| 2010 | 95.0% | +0.0% |
| 2011 | 95.0% | +0.0% |
| 2012 | 99.0% | +4.2% |
| 2013 | 99.0% | +0.0% |
| 2014 | 99.0% | +0.0% |
| 2015 | 99.0% | +0.0% |
| 2016 | 99.0% | +0.0% |
| 2017 | 99.0% | +0.0% |
| 2018 | 88.0% | -11.1% |
| 2019 | 87.0% | -1.1% |
| 2020 | 84.0% | -3.4% |
| 2021 | 98.0% | +16.7% |
| 2022 | 96.0% | -2.0% |
| 2023 | 95.0% | -1.0% |
| 2024 | 93.0% | -2.1% |
Malaysia compared with similar countries
- Malaysia's 93.0% is above the median for upper middle income countries, which is 84.5%, 1.1× the median. (56 countries reporting)
- Malaysia's 93.0% is above the median for East Asia & Pacific, which is 87.0%, 1.1× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.2% | 90.0% | 95.0% | 5 |
| 2010s | 95.9% | 87.0% | 99.0% | 10 |
| 2020s | 93.2% | 84.0% | 98.0% | 5 |
Countries ranked near Malaysia
More health data for Malaysia
- Un projection of annual infant deaths, annual growth rate -0.9119 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2888 % change on previous year (2090)
- Un projection of annual infant deaths 652 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 18 (2025)
- Population ages 00-04, female, annual growth rate -0.7207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0297 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5991 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0316 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in Malaysia?
- Immunization, measles second dose in Malaysia was 93.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Malaysia?
- The highest recorded value was 99.0% in 2012.
- What is the lowest immunization, measles second dose recorded in Malaysia?
- The lowest recorded value was 84.0% in 2020.
- How does Malaysia rank for immunization, measles second dose?
- Malaysia ranks 45th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Malaysia?
- Over the last ten years it is down 6.1%. The long-run trend across the full record is flat.
- Where does this Malaysia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.